Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of therat carotid artery
Eh. Ohlstein et al., Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of therat carotid artery, CARDIO RES, 47(4), 2000, pp. 759-768
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: Recent studies suggest that tranilast inhibits a variety of agen
ts implicated in neointimal growth and restenosis in experimental animal mo
dels and humans. We report here a study evaluating the efficacy of tranilas
t in the rat carotid artery balloon angioplasty model, a model that mimics
many aspects of the percutaneous transluminal angioplasty procedure in huma
ns. Efficacy was determined based on in vivo and ex vivo magnetic resonance
imaging (MRI) as well as by histomorphometry. The utility of this study, u
sing a reverse paradigm, is to investigate if agents successful in the clin
ic can demonstrate efficacy in this animal model primary screen as measured
by MRI and histomorphometry. Methods: Tranilast (300 mg/kg/day, p.o.) was
administered to Sprague-Dawley rats 3 days prior to balloon injury and cont
inued for 14 days after injury. Three methods of measuring the vascular inj
ury that occurs in this model were employed: (1)in vivo MRI, used to measur
e in vivo lumen volumes for the carotid artery once at baseline (pre-surger
y) and again at 14 days post angioplasty; (2) ex vivo MRI (and histomorphom
etry), used to evaluate the total arterial wall thickness and the intima-to
-media ratio; and (3) analysis of collagen density, used to evaluate the ef
ficacy of tranilast to abrogate collagen synthesis and deposition following
vascular injury. Results: Tranilast provided 33% protection (P<0.05) from
angioplasty-induced lumen narrowing as measured by MRI in vivo. The results
of the ex vivo MR analysis of total wall thickness showed a 14% protection
of angioplasty-induced narrowing (P<0.05), and the mean intima-to-media ra
tio showed a 39% (P<0.006) protection for the tranilast-treated rats. Histo
logical analysis of the mean intima-to-media ratio demonstrated that tranil
ast provided 36% (P<0.01) protection in the intima-to-media ratio. Further,
treatment with tranilast showed a 52% reduction in collagen density of the
intimal layer and a 70% reduction in collagen density of the medial layer
of the injured arteries. Conclusion: The data obtained by in vivo MRI, ex v
ivo MRI, histology and collagen analysis demonstrate that tranilast provide
d significant beneficial effects in inhibiting neointimal formation in the
rat carotid artery model. Also this study, to the best of our knowledge, is
the first to harness complimentary information from various technologies,
including lumen patency by in vivo MRI, neointimal formation by ex vivo MRI
and conventional histomorphometry, and histological analysis for collagen
density, to provide a comprehensive understanding of the pathology in this
disease model. (C) 2000 Elsevier Science B.V. All rights reserved.